Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joyce C Niland

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Cancer|October 2, 2012
Smoking status and survival in the national comprehensive cancer network non-small cell lung cancer cohortAmy K Ferketich, Joyce C Niland, Rizvan Mamet, et al.
Cancer|May 1, 2012
Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer NetworkNancy U Lin, Ann Vanderplas, Melissa E Hughes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2008
Chemotherapy use for hormone receptor-positive, lymph node-negative breast cancerMichael J Hassett, Melissa E Hughes, Joyce C Niland, et al.
Cell Transplantation|August 15, 2012
Standardized transportation of human islets: an islet cell resource center study of more than 2,000 shipmentsJohn S Kaddis, Matthew S Hanson, James Cravens, et al.
Cancer|February 10, 2010
The impact of breast reconstruction on the delivery of chemotherapyAmy K Alderman, E Dale Collins, Anne Schott, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 17, 2009
Concordance with NCCN Colorectal Cancer Guidelines and ASCO/NCCN Quality Measures: an NCCN institutional analysisDorothy Romanus, Martin R Weiser, John M Skibber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2008
Comparison of referring and final pathology for patients with non-Hodgkin's lymphoma in the National Comprehensive Cancer NetworkAnn S LaCasce, Michelle E Kho, Jonathan W Friedberg, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 10, 2009
Predictors and temporal trends of adjuvant aromatase inhibitor use in breast cancerTiffany H Svahn, Joyce C Niland, Robert W Carlson, et al.
Breast Cancer Research : BCR|October 3, 2012
Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort studyInes Vaz-Luis, Rebecca A Ottesen, Melissa E Hughes, et al.
Leukemia & Lymphoma|November 22, 2011
High rates of surveillance imaging for treated diffuse large B-cell lymphoma: findings from a large national databaseGregory A Abel, Ann Vanderplas, Maria A Rodriguez, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Cancer|October 2, 2012
Smoking status and survival in the national comprehensive cancer network non-small cell lung cancer cohortAmy K Ferketich, Joyce C Niland, Rizvan Mamet, et al.
Cancer|May 1, 2012
Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer NetworkNancy U Lin, Ann Vanderplas, Melissa E Hughes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2008
Chemotherapy use for hormone receptor-positive, lymph node-negative breast cancerMichael J Hassett, Melissa E Hughes, Joyce C Niland, et al.
Cell Transplantation|August 15, 2012
Standardized transportation of human islets: an islet cell resource center study of more than 2,000 shipmentsJohn S Kaddis, Matthew S Hanson, James Cravens, et al.
Cancer|February 10, 2010
The impact of breast reconstruction on the delivery of chemotherapyAmy K Alderman, E Dale Collins, Anne Schott, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 17, 2009
Concordance with NCCN Colorectal Cancer Guidelines and ASCO/NCCN Quality Measures: an NCCN institutional analysisDorothy Romanus, Martin R Weiser, John M Skibber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2008
Comparison of referring and final pathology for patients with non-Hodgkin's lymphoma in the National Comprehensive Cancer NetworkAnn S LaCasce, Michelle E Kho, Jonathan W Friedberg, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 10, 2009
Predictors and temporal trends of adjuvant aromatase inhibitor use in breast cancerTiffany H Svahn, Joyce C Niland, Robert W Carlson, et al.
Breast Cancer Research : BCR|October 3, 2012
Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort studyInes Vaz-Luis, Rebecca A Ottesen, Melissa E Hughes, et al.
Leukemia & Lymphoma|November 22, 2011
High rates of surveillance imaging for treated diffuse large B-cell lymphoma: findings from a large national databaseGregory A Abel, Ann Vanderplas, Maria A Rodriguez, et al.
Pageof 6